530021 南宁, 广西医科大学第一附属医院血管外科
Received:15 June 2017,
Revised:2017-07-06,
Published:15 November 2017
移动端阅览
Jing CHEN, Zhong QIN, Jiangfeng ZHANG, et al. Efficacy of high ligation of great saphenous vein combined with sclerotherapy using polidocanol foam for varicose ulcer of the lower extremities[J]. Journal of Third Military Medical University, 2017, 39(21): 2135-2139.
Jing CHEN, Zhong QIN, Jiangfeng ZHANG, et al. Efficacy of high ligation of great saphenous vein combined with sclerotherapy using polidocanol foam for varicose ulcer of the lower extremities[J]. Journal of Third Military Medical University, 2017, 39(21): 2135-2139. DOI: 10.16016/j.1000-5404.201706084.
目的
2
研究大隐静脉高位结扎联合聚多卡醇硬化治疗下肢静脉性溃疡的效果。
方法
2
将2014年1月至2016年5月在我科进行治疗的316例(411腿)下肢静脉性溃疡患者纳入研究。将患者依照随机数字表法分为结扎联合硬化组(
n
=114,150腿)、硬化剂组(
n
=89,116腿)、结扎组(
n
=113,145腿)。结扎联合硬化组患者采用大隐静脉高位结扎联合硬化剂注射,硬化剂组给予局部硬化剂注射,结扎组患者单纯进行大隐静脉高位结扎。于术前及术后12个月,由患者填写阿伯丁静脉曲张问卷(aberdeen varicose vein questionnaire
AVVQ)对其生活质量进行评估,由上级医师采用静脉临床严重程度评分表(venous clinical severity,VCSS)对患者静脉曲张及溃疡情况进行评价。记录溃疡术后所需愈合时间,测量溃疡面积,统计治疗1、3个月及6个月后溃疡治愈情况。
结果
2
术后12个月3组AVVQ及VCSS评分均较术前降低,结扎联合硬化组患者术后两项评分较另两组更低,差异具有统计学意义(
P
<
0.05)。结扎联合硬化组患者溃疡愈合时间为(26.87±12.60) d,低于硬化剂组的(32.75±14.84) d及结扎组的(30.36±13.47) d,差异具有统计学意义(
t
=2.016,
P
=0.045)。3组术后1个月及3个月溃疡与术前相比逐渐缩小(
P
<
0.05),且结扎联合硬化组溃疡相比另两组愈合较快,愈合率较高(
P
<
0.05)。3组患者均无严重并发症发生。
结论
2
大隐静脉高位结扎联合聚多卡醇硬化治疗能够有效治愈大隐静脉曲张所致下肢静脉性溃疡;联合治疗在患者生活质量、溃疡愈合速度、不良反应发生率等方面效果优于单纯硬化剂注射法。
Objective
2
To study the therapeutic efficacy of high ligation of great saphenous vein combined with sclerotherapy using polidocanol foam in the treatment of varicose ulcer of the lower extremities.
Methods
2
Three-hundred and sixteen patients (401 limbs in total) with varicose ulcer who were treated in our department from January 2014 to M
ay 2016 were enrolled in this study. The patients were randomized into 3 groups: ligation plus sclerotherapy group (LS group
n
=114
150 limbs
treated with high ligation of great saphenous vein combined with sclerotherapy)
sclerotherapy group (S group
n
=89
116 limbs
injected with polidocanol foam)
and ligation group (L group
n
=113
145 limbs treated with high ligation alone). Patients' conditions were evaluated using Aberdeen varicose vein questionnaire (AVVQ) and Venous clinical severity (VCSS) before operation and in 12 months after operation. The healing time and ulcerous area were recorded. The healing rate of ulcer at 1
3 and 6 months after treatment among the groups were compared.
Results
2
The AVVQ and VCSS scores were notably decreased at 12 months after treatment (
P
<
0.05). The LS group had the lowest scores
which significantly differed from the other 2 groups (
P
<
0.05). The median healing time of ulcer was 26.87±12.60 d in the LS group
32.75±14.84 d in the S group
and 30.36±13.47 d in the L group. The difference was statistically significant (
t
=2.016
P
=0.045). Also
the ulcer area was gradually shrunk over the time (
P
<
0.05). At 1 and 3 months after surgery
the LS group had a higher healing rate than the L and S groups (
P
<
0.05). No severe complications occurred.
Conclusion
2
High ligation of great saphenous vein combined with sclerotherapy using polidocanol foam is an efficient and safe treatment for varicose ulcer of the lower extremities. Compared with sclerotherapy or high ligation treatment alone
the combination strategy can effectively improve patients' life quality and promote ulcer healing rate without causing severe complications.
JIA X, MOWATT G, BURR J M, et al. Systematic review of foam sclerotherapy for varicose veins[J]. Br J Surg, 2007, 94(8): 925-936. DOI: 10.1002/bjs.5891.
梁卫, 张纪蔚.复发性静脉曲张的分类和治疗进展[J].中国血管外科杂志(电子版), 2016, 8(3): 175-177, 182. DOI: 10.3969/j.issn.1674-7429. 2016.03.003.
LIANG W, ZHANG J W. The progress of classification and treatment of recurrent varicose veins[J]. Chin J Vasc Surg (Electronic Version), 2016, 8(3): 175-177, 182. DOI:10.3969/j.issn.1674-7429.2016.03.003.
朱永强, 徐敬宣, 陈俊英, 等.透视引导下聚桂醇泡沫硬化剂治疗下肢静脉曲张的疗效观察[J].中华放射学杂志, 2012, 46(9): 836-839. DOI: 10.3760/cma.j.issn.1005-1201.2012.09.014.
ZHU Y Q, XU J X, CHEN J Y, et al. The clinical efficacy observation of fluoroscopy-guided foam sclerotherapy with lauromacrogol for varicose veins of the lower extremities[J]. Chin J Radiol, 2012, 46(9): 836-839. DOI: 10.3760/cma.j.issn.1005-1201.2012.09.014.
覃忠, 覃晓, 郭思恩, 等.泡沫硬化剂联合手术治疗在下肢静脉曲张中的应用[J].广西医科大学学报, 2015, 32(6): 944-946.DOI:10.16190/j.cnki.45-1211/r.2015.06.025.
QIN Z, QIN X, GUO S E, et al.Application of foam sclerosing agent combined with surgical treatment in varicose veins of lower extremity[J]. J Guangxi Med Univ, 2015, 32(6): 944-946. DOI: 10.16190/j.cnki.45-1211/r.2015.06.025.
EKLOF B, RUTHERFORD R B, BERGAN J J, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement[J]. Journal of Vascular Surgery, 2004, 40(6): 1248-1252. DOI: 10.1016/j.jvs. 2004.09.027.
STANISZEWSKA A, TAMBYRAJA A, AFOLABI E, et al. The aberdeen varicose vein questionnaire, patient factors and referral for treatment [J]. Eur J Vasc Endovasc Surg, 2013, 46(6): 715-718. DOI: 10.1016/j.ejvs.2013. 08.019.
SUBRAMONIA S, LEES T A. The treatment of varicose veins[J]. Ann R Coll Surg Engl, 2007, 89(2): 96-100. DOI: 10.1308/003588407X168271.
CENTRE N C G. Varicose veins in the legs: the diagnosis and management of varicose veins [J]. British Journal of General Practice, 2014, 64(623): 314-315. DOI:10.3399/bjgp14x680329.
NESBITT C, WILSON W R, LEES T A, et al. Interpretation of patient-reported outcome measures for varicose vein surgery[J]. Phlebology, 2012, 27(4): 173-178. DOI: 10.1258/phleb.2011.011013.
HARLANDER-LOCKE M, LAWRENCE P F, ALKTAIFI A, et al. The impact of ablation of incompetent superficial and perforator veins on ulcer healing rates[J]. J Vasc Surg, 2012, 55(2): 458-464. DOI: 10.1016/j.jvs. 2011.08.054.
RABE E, OTTO J, SCHLIEPHAKE D, et al. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial[J]. Eur J Vasc Endovasc Surg, 2008, 35(2): 238-245. DOI: 10.1016/j.ejvs.2007.09.006.
DARVALL K A, BATE G R, BRADBURY A W. Patient-reported outcomes 5-8?years after ultrasound-guided foam sclerotherapy for varicose veins [J]. Br J Surg, 2014, 101(9): 1098-1104. DOI: 10.1002/bjs. 9581.
CAVEZZI A, FRULLINI A, RICCI S, et al. Treatment of varicose veins by foam sclerotherapy: Two clinical series[J]. Phlebology, 2002, 17(1): 13-18. DOI: 10.1007/s005230200023.
彭程, 周智勇, 王凯, 等.大隐静脉高位结扎联合导管泡沫硬化剂治疗下肢静脉曲张[J].中国血管外科杂志(电子版), 2014, 6(2): 107-109. DOI: 10.3969/j.issn.1674-7429.2014.02.013.
PENG C, ZHOU Z Y, WANG K, et al. High ligation of great saphenous vein combined with catheter foam sclcrotherapy in varicose veins[J]. Chin J Vasc Surg (Electronic Version), 2014, 6(2): 107-109. DOI: 10.3969/j.issn.1674-7429.2014.02.013.j.issn.1674-7429.2014.02.013.
梁奇伟, 冯惠岗, 庄炜钊, 等.透视下聚多卡醇硬化治疗C5~C6期下肢静脉性溃疡的疗效[J].中华介入放射学电子杂志, 2016, 4(4): 216-220. DOI: 10.3877/cma.j.issn.2095-5782.2016.04.007.
LIANG Q W, FENG H G, ZHUANG W Z, et al.X ray-guided foam sclerotherapy with polidocanol in the treatment of lower extremity varicose ulcer[J]. Chin J Inter Rad (Electronic Edition), 2016, 4(4): 216-220. DOI: 10.3877/cma.j.issn.2095-5782.2016.04.007.
王林君, 董阳民, 王松茂, 等.超声引导下聚多卡醇泡沫硬化剂治疗大隐静脉曲张的早期临床疗效分析[J].中国普通外科杂志, 2016, 25(6): 931-933, 934. DOI: 10.3978/j.issn.1005-6947.2016.06.028.
WANG L J, DONG Y M, WANG S M, et al. Analysis of the early clinical efficacy of ultrasound-guided polidocanol foam sclerotherapy of varicose vein[J]. Chin J Gen Surg, 2016, 25(6): 931-934. DOI: 10.3978/j.issn.1005-6947.2016.06.028.
傅建华, 何旭, 王亚非, 等.下肢静脉曲张硬化治疗的现状与进展[J].介入放射学杂志, 2011, 20(9): 753-756. DOI: 10.3969/j.issn.1008-794X. 2011.09.023.
FU J H, HE X, WANG Y F, et al.The sclerotherapy of varicose veins of the lower limbs:its current situation and recent progress[J]. J Inter Rad, 2011, 20(9): 753-756. DOI: 10.3969/j.issn.1008-794X.2011.09.023.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
